Abstract C20: Smpd3 augments chemotherapy and thwarts PDA progression
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Research"
DOI: 10.1158/1538-7445.panca19-c20
Abstract: Deregulated sphingolipid metabolism alters pancreatic cancer progression; for that reason, bioactive lipid signaling molecules such as ceramide show promise as both biomarkers for disease progression and novel therapeutic targets. Intracellular ceramide levels are critical for… read more here.
Keywords: expression; smpd3; progression; pda progression ... See more keywords